scholarly journals Health Service Research in Integrative Oncology: Viscum Album Use and Non-Pharmacotherapeutic Interventions in Lung Cancer Patients

2012 ◽  
Vol 23 ◽  
pp. ix466
Author(s):  
F. Schad ◽  
J. Axtner ◽  
A. Happe ◽  
T. Breitkreuz ◽  
J. Gutsch ◽  
...  
2013 ◽  
Vol 31 (15_suppl) ◽  
pp. e20710-e20710
Author(s):  
Friedemann Schad ◽  
Jan Axtner ◽  
Antje Happe ◽  
Matthias Kroez ◽  
Burkhard Matthes ◽  
...  

e20710 Background: Early palliative care was demonstrated to result in a superior survival and improvement of health related quality of live (HRQL) in patients with advanced lung cancer. Concepts of integrative oncology (IO) offer multimodal therapy strategies aiming to enhance patients’ salutogenic resources in addition to standard care. In the present study we analyzed patients with advanced lung cancer from a clinical registry in Germany. Methods: Data were collected by the Network Oncology, a clinical registry of hospitals and outpatients care specialized in Anthroposophic Medicine and integrative oncology. We analyzed 441 C34 patients of UICC stage IV that had at least one of the following additional therapies: Viscum album, embrocation, therapeutic unction’s, rhythmical massages, lymph drainage, physiotherapy, eurythmy therapy, music or drawing therapy, modeling, speech-, breathing and hyperthermia therapy. We calculated Kaplan-Meier survival based on right censored data and using Greenwoods 95% confidence intervals. Results: 43% of the patients were female and median age was 64 yr (min 32/ max 92). 84% received chemotherapy, 55% radiation and 40% surgery. Most frequent additional therapies were Viscum album (72%), embrocation (43%), therapeutic unction (42%), eurythmy therapy and physiotherapy (both 27%). Patients used combinations up to 9 different additional therapies (median ♀=3, median ♂=2) with significant difference between genders (Fisher’s exact test, < p=0.001). Median length of VA therapy was 6.4 months. Median OS was 1.05yr (95% CI: 0.83 - 1.32), 2 and 3 year survival was 31% and 20%, respectively. Conclusions: Integrative therapy concepts are of growing interest in cancer care. In this observational study patients received conventional and complementary interventions. A relevant number of lung cancer patient use IO when offered in palliative oncology. Median OS seems to be comparable to the palliative care group of Temel et al. 2010 (median OS=0.97yr, 95% CI: 0.53 – 1.41). Health service research in multimodal IO settings needs further evaluation in terms of HRQL measurement and effectiveness.


2014 ◽  
Vol 23 (7) ◽  
pp. 812-819 ◽  
Author(s):  
Catherine E. Mosher ◽  
Joseph G. Winger ◽  
Nasser Hanna ◽  
Shadia I. Jalal ◽  
Achilles J. Fakiris ◽  
...  

2012 ◽  
Vol 4 ◽  
pp. 19-20
Author(s):  
Schad Friedemann ◽  
Axtner Jan ◽  
Happe Antje ◽  
Matthes Burkhard ◽  
Grah Christian ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-9
Author(s):  
Anja Thronicke ◽  
Phillipp von Trott ◽  
Matthias Kröz ◽  
Christian Grah ◽  
Burkhard Matthes ◽  
...  

Background. Pretreatment health-related quality of life (HRQOL) is associated with survival outcome in lung cancer patients. There is a lack of systematic research on pretreatment HRQOL in lung cancer patients who receive integrative oncology (IO). We evaluated patient-reported outcomes in these patients at time of diagnosis at a certified oncology and lung cancer centre. Methods. The present analysis is a prospective real-world data study. Clinical and demographic data were obtained from the accredited Network Oncology cancer registry. Pretreatment HRQOL was evaluated (international standardized questionnaires) for people with all-stage lung cancer at first diagnosis that received IO consisting of standard therapy and multimodal add-on complementary concepts. Univariate and adjusted multivariate regression analyses were performed with R. Results. Eighty seven patients with all-stage lung cancer were eligible for the questionnaire analysis (median age 68.0 years, IQR 59.0–74.4). Thirty percent of the total cohort reported financial difficulties. Self-reported pretreatment financial difficulty was associated with younger age (p=0.007), pretreatment pain (p=0.006), anxiety (p=0.04), and low mood (p=0.03). Pain (p=0.03) and young age (p=0.02) in the early- and late-stage lung cancer were associated with financial difficulties. Conclusion. We suggest physicians screen lung cancer patients at working age (broadly aged ≤65 years) and/or who report increased pain at the time of diagnosis as they might be at particular risk for emotional, physical, and financial problems. Our results emphasize to address emotional and physical needs before and during early treatment in lung cancer patients as suggested in integrative and supportive cancer concepts.


2012 ◽  
Vol 23 ◽  
pp. iv83-iv84
Author(s):  
Friedemann Schad ◽  
Jan Axtner ◽  
Antje Happe ◽  
Thomas Breitkreuz ◽  
Constantin Paxino ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document